Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Shinichi KAKUMU"'
Autor:
Naoki Hotta, Minoru Ayada, Akihiko Okumura, Tetsuya Ishikawa, Ken Sato, Tomohiko Oohashi, Yasutaka Hijikata, Shinichi Kakumu
Publikováno v:
Case Reports in Gastroenterology, Vol 3, Iss 2, Pp 175-181 (2009)
A 41-year-old Japanese man had received successful interferon (IFN) therapy against chronic hepatitis C in 1994. Since then, serum hepatitis C virus (HCV) RNA had been negative, and aminotransferase levels had been continuously normal. He had abstain
Externí odkaz:
https://doaj.org/article/e10543d25e7a4d63b533bf4e0bb87105
Autor:
Tetsuya Ishikawa, Shinichi Kakumu, Ken Sato, Haruhisa Nakao, Tomohiko Ohashi, Akihiko Okumura, Jun-Ichi Tanabe, Minoru Ayada, Hiroyasu Ito, Teiji Kuzuya, Naoki Hotta, Masashi Yoneda
Publikováno v:
Hepatology Research. 39:510-519
Aim Human hepatocytes are known to express an array of inflammatory cytokines and chemokines. In this study, we examined the potential roles of hepatocytes in regulating immune responses in the liver, by assessing the induction of Th1- or Th2-specifi
Autor:
Akihiko Okumura, Minoru Ayada, Tetsuya Ishikawa, Shinichi Kakumu, Ken Sato, Yasutaka Hijikata, Naoki Hotta, Tomohiko Oohashi
Publikováno v:
Case Reports in Gastroenterology
Case Reports in Gastroenterology, Vol 3, Iss 2, Pp 175-181 (2009)
Case Reports in Gastroenterology, Vol 3, Iss 2, Pp 175-181 (2009)
A 41-year-old Japanese man had received successful interferon (IFN) therapy against chronic hepatitis C in 1994. Since then, serum hepatitis C virus (HCV) RNA had been negative, and aminotransferase levels had been continuously normal. He had abstain
Autor:
Akinori Hirose, Shinichi Kakumu, Naoki Hotta, Akihiko Okumura, Minoru Ayada, Kazuo Masuko, Tetsuya Ishikawa
Publikováno v:
Kanzo. 50:139-144
Publikováno v:
Liver. 9:14-19
Our study was undertaken to determine whether human recombinant interferon alpha(rIFN alpha), gamma(rIFN gamma), and tumor necrosis factor alpha(rTNF alpha) exert an effect on the HLA-A, B, C expression of human liver cell lines. The HLA-A, B, C expr
Publikováno v:
Journal of Gastroenterology. 43:866-874
DNA microarray technology has enabled genomewide analysis of gene transcript levels, yielding insight into the molecular nature of liver disease. We compared gene expression of liver biopsy specimens in 16 patients with different stages of chronic he
Publikováno v:
Hepatology Research. 38:673-682
AIM DNA microarray technology has enabled genome-wide analysis of gene transcript levels, which has yielded insight into the molecular nature of hepatitis C virus infection. However, little insight into the molecular nature of the early to advanced s
Autor:
Michio Kato, Harumasa Yoshihara, Norio Hayashi, Tsugiko Oze, Nao Kurashige, Akinori Kasahara, Sumio Kawata, Shinichi Kakumu, Takeshi Okanoue, Tetsuo Takehara, Hirohito Tsubouchi, Masahide Oshita, Hiromitsu Kumada, Shinji Tamura, Naoki Hiramatsu, Kazuhiro Katayama, Yasuharu Imai
Publikováno v:
Hepatology Research. 38:52-59
Aim: Ribavirin, used to treat chronic hepatitis C, can induce hemolytic anemia, forcing the discontinuance of treatment. To establish a predictive measure to help circumvent this, we evaluated the relationship of hemoglobin (Hb) decline with the disc
Autor:
Shinichi Kakumu, Tetsuya Ishikawa
Publikováno v:
Hepatology Research. 37:S347-S350
Current therapeutic approaches to control chronic hepatitis B (CH-B), such as administrations of interferon or nucleoside analogs, are still unsatisfactory. Vaccination with conventional hepatitis B (HB) vaccine is another therapeutic approach with l
Autor:
Tetsuya Ishikawa, Shinichi Kakumu
Publikováno v:
Hepatology Research. 37:S62-S66
BACKGROUND AND AIM Lamivudine (LAM) has problems of breakthrough hepatitis (BTH) and post-treatment relapse despite its significant effect for suppressing hepatitis B virus (HBV) replication. In order to find solutions for the problems, the efficacy